PharmaRadar360

Entity and regulatory intelligence

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 687 of 767

Advanced search

🇫🇷May 4Researchpresse.inserm.frTier 2 · Direct publisher

Démangeaisons et inflammation de la peau : l’implication étonnante de nos neurones

INSERMOriginal source

🇮🇱May 4Industrytevapharm.comTier 1 · Company source

Action & Accountability: Highlights of Teva’s ESG Progress in 2021

Teva PharmaceuticalsOriginal source

🇮🇱May 4Industrytevapharm.comTier 1 · Company source

ESG Progress Report | Our Impact | Teva Pharmaceuticals

Teva PharmaceuticalsOriginal source

🇮🇱May 4Industrytevapharm.comTier 1 · Company source

2020 ESG Highlights Infographic

Teva PharmaceuticalsOriginal source

🇮🇱May 4Industrytevapharm.comTier 1 · Company source

ESG Progress Report | Our Impact | Teva Pharmaceuticals

Teva PharmaceuticalsOriginal source

🇮🇱May 4Industrytevapharm.comTier 1 · Company source

ESG Progress Report 2022

Teva PharmaceuticalsOriginal source

🇮🇱May 4Industrytevapharm.comTier 1 · Company source

ESG Progress Report | Our Impact | Teva Pharmaceuticals

Teva PharmaceuticalsOriginal source

🇮🇱May 4Industrytevapharm.comTier 1 · Company source

2023 ESG Highlights Infographic

Teva PharmaceuticalsOriginal source

🇮🇱May 4Industrytevapharm.comTier 1 · Company source

Teva 2024 Healthy Future Report: Creating the Future We Want to See

Teva PharmaceuticalsOriginal source

🇮🇱May 4Industrytevapharm.comTier 1 · Company source

Healthy Future Report 2023

Teva PharmaceuticalsOriginal source

🇺🇸May 4CDMOagcbio.comTier 2 · Direct publisher

Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate

AGC BiologicsOriginal source

🌍May 2CROcrucialdatasolutions.comTier 2 · Direct publisher

What Is an eCRF?

TrialKitOriginal source

🌍May 2CROcrucialdatasolutions.comTier 2 · Direct publisher

EDC Software: The Best Clinical Trial Software for CROs

TrialKitOriginal source

🇯🇵May 1Researchmed.kyoto-u.ac.jpTier 2 · Direct publisher

Prof. Manabu Hasegawa has taken up his post in the Department of Capacity Development in Health Emergency and Crisis Management, Center for Health Security

Kyoto University Faculty of MedicineOriginal source

🌍May 1Industryintercure.coTier 1 · Company source

20F - Annual Report of the financial statments as of December 31, 2025

InterCureOriginal source

🇺🇸May 1CDMOinvestors.emergentbiosolutions.comTier 2 · Direct publisher

Emergent BioSolutions Reports First Quarter 2026 Financial Results

Emergent BioSolutionsOriginal source

🌍May 1Regulatorytransceleratebiopharmainc.comTier 1 · Regulatory source

Why Protocol Complexity Keeps Increasing – and How to Fix It

TransCelerate BioPharmaOriginal source

🌍Apr 30Industryorchestrabiomed.comTier 1 · Company source

Strengthening AVIM Therapy’s Regulatory Pathway: A Second FDA Breakthrough Device Designation

Orchestra BioMedOriginal source

🌍Apr 30Mediavalneva.comTier 2 · Direct publisher

Why Prevention Must be at the Center of the Lyme Disease Response

ValnevaOriginal source

🇺🇸Apr 30CROcaidya.comTier 2 · Direct publisher

Data Protection and Cross-Border Transfers — Ensuring GDPR Compliance in Multinational Trials

Caidya (Clinipace)Original source

🇺🇸Apr 30Industrybioreference.comTier 1 · Company source

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

BioReference LaboratoriesOriginal source

🇺🇸Apr 30CROir.criver.comTier 2 · Direct publisher

Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities

Charles River LaboratoriesOriginal source

🇺🇸Apr 30CDMOinvestors.emergentbiosolutions.comTier 2 · Direct publisher

Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox

Emergent BioSolutionsOriginal source

🌍Apr 30Industryaptose.comTier 1 · Company source

Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical

Aptose BiosciencesOriginal source

🇫🇷Apr 30Researchpresse.inserm.frTier 2 · Direct publisher

Intra-tumour immunotherapy: mobilising the immune system against cancer while avoiding toxicity to the body

INSERMOriginal source

🇺🇸Apr 30Devicesviz.aiTier 1 · Company source

Viz.ai and National Rural Health Association Launch Initiative to Bring AI-Powered Detection and Care Coordination to Rural Hospitals

Viz.aiOriginal source

🇺🇸Apr 30Industrybambusatx.comTier 1 · Company source

Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis

Bambusa TherapeuticsOriginal source

🇸🇬Apr 30Researchscri.edu.sgTier 2 · Direct publisher

Clinical Research Coordinator Level 1 Programme (January 2026 Intake)

Singapore Clinical Research InstituteOriginal source

🇺🇸Apr 30Industrybeamtx.comTier 1 · Company source

Breaking new ground to advance science with the potential to change lives | Beam Therapeutics

Beam TherapeuticsOriginal source

🌍Apr 29Industryorthofix.comTier 1 · Company source

Addressing Graft Migration in Posterolateral Fusion with OsteoBallast™

OrthofixOriginal source

🇺🇰Apr 29Researchphar.cam.ac.ukTier 2 · Direct publisher

Paper Spotlight: Cav3.1 is a neuronal leucine sensor that mediates satiety and weight loss in response to dietary protein

Cambridge Pharma ResearchOriginal source

🌍Apr 29Industryadial.comTier 1 · Company source

Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045

Adial PharmaceuticalsOriginal source

🇯🇵Apr 29CROen.cmicgroup.comTier 2 · Direct publisher

CRM Trial Connect 2026

CMIC Group JapanOriginal source

🇺🇸Apr 29Industryir.codexis.comTier 1 · Company source

Codexis to share RNA manufacturing advances at TIDES USA

CodexisOriginal source

🇨🇭Apr 29CDMOsiegfried.chTier 2 · Direct publisher

Siegfried DINAMIQS receives Swissmedic license for viral vector manufacturing

SiegfriedOriginal source

🇸🇬Apr 29Regulatoryapacmed.orgTier 1 · Regulatory source

Across the Codes: Navigating MedTech Compliance Expectations in the Region

APACMedOriginal source

🌍Apr 29Industryrss.globenewswire.comTier 3 · Secondary coverage

GH Research Announces Pricing of $117.5 Million Underwritten Offering

GH ResearchOriginal source

🇺🇸Apr 29Researcharchventure.comTier 2 · Direct publisher

ARCH-backed Paradigm Health partners with FDA to provide technology platform for real-time clinical trial monitoring

ARCH Venture PartnersOriginal source

🌍Apr 29Researchopenclinica.comTier 2 · Direct publisher

Leading Academic Center: Freeing Teams from Maintenance to Focus on Research

OpenClinicaOriginal source

🌍Apr 28Industryorchestrabiomed.comTier 1 · Company source

From Blood Pressure Reduction to Cardiac Function: What New AVIM Therapy Data Signal

Orchestra BioMedOriginal source

🌍Apr 28Mediarhoworld.comTier 2 · Direct publisher

Regulatory Friction You Don’t See Coming in Clinical Development

RhoOriginal source

🌍Apr 28Industrybenitec.comTier 1 · Company source

Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting

Benitec BiopharmaOriginal source

🌍Apr 28Industryir.biolinerx.comTier 1 · Company source

BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)

BioLineRxOriginal source

🇺🇸Apr 28Researchmdanderson.orgTier 2 · Direct publisher

Bladder cancer treatment: The importance of accurate diagnosis and staging

MD Anderson Cancer CenterOriginal source

🌍Apr 28Industryuk-cpi.comTier 1 · Company source

CPI strengthens route to market for novel foods with expanded pilot-scale capability

CPI (Healthcare Innovation)Original source

🌍Apr 28Mediaoxipit.aiTier 2 · Direct publisher

Leading Oxipit’s next chapter

Oxipit (ChestLink for Thoracic X-ray/CT)Original source

🇯🇵Apr 28pharma_equipmentprodcms.ulvac.co.jpTier 2 · Direct publisher

Notice of Change in Business Operations Structure in Malaysia

Ulvac (Pharma)Original source

🇯🇵Apr 28pharma_equipmentprodcms.ulvac.co.jpTier 2 · Direct publisher

Sales Termination of DC Power supply DC-2, DC-4

Ulvac (Pharma)Original source

🌍Apr 28Industryxoma.comTier 1 · Company source

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

Xoma CorporationOriginal source

🇺🇸Apr 28Devicesbtig.comTier 1 · Company source

BTIG to Host 20th Commissions for Charity Day on May 6, 2026 – Clients, Celebrities and Employees Join Together to Support Charities Worldwide

BTIGOriginal source

🇺🇸Apr 27CDMOagcbio.comTier 2 · Direct publisher

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

AGC BiologicsOriginal source

🇫🇷Apr 27Researchpresse.inserm.frTier 2 · Direct publisher

Pancreatic cancer: an antibody proves itself in an early clinical trial

INSERMOriginal source

🌍Apr 27Industryadial.comTier 1 · Company source

Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program

Adial PharmaceuticalsOriginal source

🌍Apr 27Industrycormedix.comTier 1 · Company source

CORMEDIX THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE III RESPECT TRIAL ASSESSING REZZAYO® FOR THE PROPHYLAXIS OF INVASIVE FUNGAL DISEASES IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS

CorMedixOriginal source

🌍Apr 27Industrynervgen.comTier 1 · Company source

NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer

NervGen PharmaOriginal source

🌍Apr 27Regulatoryinfarma.plTier 1 · Regulatory source

KOMENTARZ z okazji Światowego Dnia Własności Intelektualnej. prof. Rafał Sikorski, Uniwersytet im. Adama Mickiewicza w Poznaniu

INFARMA PolandOriginal source

🇫🇮Apr 27Devicesaiforia.comTier 1 · Company source

Fimlab expands utilization of Aiforia's clinical AI solutions

AiforiaOriginal source

🇯🇵Apr 27pharma_equipmentprodcms.ulvac.co.jpTier 2 · Direct publisher

Presentation at the SEMIEXPO Heartland 2026

Ulvac (Pharma)Original source

🌍Apr 27Industryzentiva.comTier 1 · Company source

Zentiva appeals EU court decision on Urban Wastewater Directive

Zentiva (Global)Original source

🇫🇷Apr 24Researchpresse.inserm.frTier 2 · Direct publisher

A major international clinical trial sheds new light on a paediatric brain cancer

INSERMOriginal source